** Hepatitis Fight Gains Ground, But Experts Urge Accelerated Push for Elimination
** Geneva, Switzerland – The World Health Organization (WHO) has issued a stark warning alongside encouraging news: while strides are being made in tackling viral hepatitis globally, the disease remains a stubbornly persistent and potentially deadly threat, demanding a significantly accelerated and intensified response. A new report published today highlights demonstrable advancements in several regions, particularly in Europe and North America, but emphasizes that current efforts are not fast enough to meet the WHO’s ambitious goal of eliminating viral hepatitis by 2030. Viral hepatitis, encompassing Hepatitis A, B, C, D, and E, is caused by infection with different strains of the hepatitis virus. Hepatitis B and C are primarily transmitted through blood-to-blood contact, often through shared needles – a legacy of the opioid crisis in several countries. Hepatitis A and E are typically spread through contaminated food and water. Hepatitis D (Delta) only occurs in people already infected with Hepatitis B, and Hepatitis E can cause severe illness in pregnant women. The WHO report details successes in expanding access to screening programs, particularly for Hepatitis C, where direct-acting antiviral (DAA) medications have proven remarkably effective in curing the infection in a relatively short period (typically 8-12 weeks). Countries like Canada, Australia, and several European nations have seen dramatic declines in new Hepatitis C infections due to aggressive screening campaigns and the rollout of these medications. However, the report underscores significant disparities. Sub-Saharan Africa and Southeast Asia continue to face the greatest challenges, with low screening rates, limited access to treatment, and a lack of comprehensive prevention programs. “We’ve seen pockets of remarkable success, particularly with Hepatitis C,” stated Dr. Maria Rodriguez, lead author of the report and a WHO hepatitis specialist. “But the reality is that millions – an estimated 750,000 people die globally each year – are still living with chronic hepatitis infections, and many don’t even know they’re infected. The window of opportunity to prevent chronic disease and death is closing.” The WHO is calling for a refocus on several key areas: significantly increased investment in testing and screening, particularly among high-risk groups (prisoners, people who inject drugs, transgender populations, and those with limited access to healthcare); scaled-up access to affordable treatment, even in low-resource settings; strengthened vaccination programs for Hepatitis A and B; and aggressive public awareness campaigns to combat stigma and promote safe practices. Experts warn that without a dramatic increase in funding and a concerted global effort, the 2030 elimination goal will remain out of reach. The report also stresses the interconnectedness of viral hepatitis with other global health challenges like HIV/AIDS and the opioid crisis, urging a holistic approach to intervention. **
Source: Read Original
** #ViralHepatitis #HepC #HepatitisB #GlobalHealth #WHO #HealthEquity #EliminateHepatitis #DiseasePrevention #PublicHealth
This news made with assistant of AI system